Shares of Avenue Therapeutics, Inc. (ATXI) are down more than 25% Friday morning at $4.89.
With effect from today, Avenues shares have started trading after 1-for-15 reverse stock split
The reverse stock split was primarily intended to bring the company into compliance with Nasdaq's $1.00 per share minimum bid price requirement for continued listing.
ATXI has traded in the range of $0.20-$6.34 in the last 1 year.
For comments and feedback contact: editorial@rttnews.com
Business News